Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/13/2779496/0/en/Senti-Bio-Announces-Third-Quarter-2023-Results-and-Pipeline-Updates.html

– IND for SENTI-202, a potential first-in-class logic-gated treatment for cancer, on track for clearance in Q4 2023 –

– Established new strategic collaboration with Celest Therapeutics for clinical development of SENTI-301A to treat liver cancer in China –

Read more at globenewswire.com

Related news for (SNTI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.